Armistice Capital »

Dermata Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Dermata Therapeutics shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Dermata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dermata Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dermata Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $410k 82k 5.02

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Dermata Therapeutics

Armistice Capital
UBS Group
Tower Research Capital
SBI Securities

View all funds holding Dermata Therapeutics